WT1 and acute myeloid leukemia: Over the past decade, a growing number of AML peptide antigens have been discovered, including those derived from Wilm’s tumor protein 1 (WT1), Proteinase 3 (PR3), receptor for hyaluronan acid-mediated motility (RHAMM), and others [7].